Sotatercept (ACE-011) Alone and with Ruxolitinib in Patients with MPN-associated Myelofibrosis (MF) and Anemia with Ruxolitinib or Hydroxyurea
Prithviraj Bose, M.D. presents from ASH 2017 results of sotatercept (ACE-011) alone and with ruxolitinib in patients with MPN-associated myelofibrosis and anemia.
Recent Video
Most Popular
Specialties :                    Search : is a member of the Oncology.TV family of oncology medical education websites. offers specialists, primary care physicians, and other healthcare professionals the timeliest comprehensive and relevant clinical information to improve patient care. We provide medical education (both free CE and non CE, including interactive case based presentations), news and information about Myeloproliferative Neoplasms (MPNs).